Related references
Note: Only part of the references are listed.Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer
Quirino Lai et al.
TRANSPLANT INTERNATIONAL (2014)
Preoperative Neutrophil-to-Lymphocyte Ratio Is a Predictor of Survival After Hepatectomy for Hepatocellular Carcinoma A Retrospective Analysis
Yohei Mano et al.
ANNALS OF SURGERY (2013)
Improving Screening for Hepatocellular Carcinoma by Incorporating Data on Levels of α-Fetoprotein, Over Time
Elliot Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma
Alpna R. Limaye et al.
HEPATOLOGY RESEARCH (2013)
Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment
Takashi Motomura et al.
JOURNAL OF HEPATOLOGY (2013)
Thrombotic Microangiopathy After Living-Donor Liver Transplantation
J. Shindoh et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma
Ho Jung An et al.
LIVER TRANSPLANTATION (2012)
Do Preoperative Inflammatory Markers Impact on Outcome After Liver Transplantation for Hepatocellular Carcinoma?
Gonzalo Sapisochin et al.
ANNALS OF SURGERY (2011)
Prognostic Factors After Early Recurrence in Patients who Underwent Curative Resection for Hepatocellular Carcinoma
Jae Min Chun et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor
E. Vibert et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Significance of Des-Gamma-Carboxy Prothrombin in Selection Criteria for Living Donor Liver Transplantation for Hepatocellular Carcinoma
M. Fujiki et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome After Liver Transplantation for Hepatocellular Carcinoma
Karim J. Halazun et al.
ANNALS OF SURGERY (2009)
High Serum Des-gamma-carboxy Prothrombin Level Predicts Poor Prognosis After Radiofrequency Ablation of Hepatocellular Carcinoma
Masahiro Kobayashi et al.
CANCER (2009)
Impact of Des-Gamma-Carboxy Prothrombin and Tumor Size on the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation
Akinobu Taketomi et al.
TRANSPLANTATION (2009)
Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma
Kenichi Hakamada et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma
D. Gomez et al.
WORLD JOURNAL OF SURGERY (2008)
Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy
Tsung-Ming Chen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation
Kathy Han et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY (2007)
Living donor liver transplantation for hepatocellular carcinoma: Tokyo university series
Yasuhiko Sugawara et al.
DIGESTIVE DISEASES (2007)
PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection
Do Young Kim et al.
ONCOLOGY (2007)
Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers
Ryosuke Tateishi et al.
HEPATOLOGY (2006)
Tailoring the type of donor hepatectomy for adult living donor liver transplantation
N Kokudo et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Living donor liver transplantation for hepatocellular carcinoma: A special reference to a preoperative des-gamma-carboxy prothrombin value
M Shimada et al.
TRANSPLANTATION PROCEEDINGS (2005)
Modified CLIP using PIVKA-II for evaluating prognosis after hepatectomy for hepatocellular carcinoma
A Nanashima et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2003)
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
FY Yao et al.
HEPATOLOGY (2001)
Share Paper
